Home Cart Sign in  
Chemical Structure| 3621-38-3 Chemical Structure| 3621-38-3

Structure of Jatrorrhizine
CAS No.: 3621-38-3

Chemical Structure| 3621-38-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Jatrorrhizine is a protoberberine alkaloid isolated from some plant species like Enantia chlorantha. It can inhibit MAO-A and MAO-B noncompetitively with IC50 value of 4μM and 62μM, respectively. Also, it has antiinflammatory, antimicrobial and antifungal activity.

Synonyms: Neprotin; Yatrorizine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Jatrorrhizine

CAS No. :3621-38-3
Formula : C20H20NO4
M.W : 338.38
SMILES Code : COC1=C(OC)C2=C[N+]3=C(C4=CC(OC)=C(O)C=C4CC3)C=C2C=C1
Synonyms :
Neprotin; Yatrorizine
MDL No. :MFCD01310242
InChI Key :MXTLAHSTUOXGQF-UHFFFAOYSA-O
Pubchem ID :72323

Safety of Jatrorrhizine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H332-H372-H400
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

Target
  • AChE

    AChE, IC50:872 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Caco-2 cells 10 μM 120 minutes To evaluate the permeability and efflux capacity of Jatrorrhizine in Caco-2 cell monolayers. Results showed a net efflux value of 1.73 ± 0.42 × 10−6 cm/s for Jatrorrhizine. Acta Pharmacol Sin. 2019 Jan;40(1):133-142
HepG2 cells 20 μM 24 hours To examine the effect of Jatrorrhizine on AMPK activity, results showed that Jatrorrhizine had no significant effect on AMPK activity. J Transl Med. 2011 May 15;9:62
HepG2 cells 40 μM 8 hours To examine the effect of Jatrorrhizine on LDLR mRNA expression, results showed that Jatrorrhizine had no significant effect on LDLR mRNA expression. J Transl Med. 2011 May 15;9:62
HepG2 cells 20 μM 8 hours To examine the effect of Jatrorrhizine on InsR mRNA expression, results showed that Jatrorrhizine increased InsR mRNA level by around 1.5 folds. J Transl Med. 2011 May 15;9:62
MNV-infected RAW264.7 macrophages 10, 20, 40 μM 48 hours To evaluate the effect of Jatrorrhizine on cytotoxicity caused by MNV infection, results showed that Jatrorrhizine significantly inhibited the reduction in cell viability caused by MNV infection Vaccines (Basel). 2023 Jan 12;11(1):164
RAW264.7 macrophages 5, 10, 20, 40, 80, 160 μM 48 hours To evaluate the effect of Jatrorrhizine on the viability of RAW264.7 macrophages, results showed that Jatrorrhizine had no significant effect on cell viability at concentrations of 5-160 μM Vaccines (Basel). 2023 Jan 12;11(1):164
human umbilical cord vein endothelial cells (HUVECs) 1 μM 48 hours To evaluate the protective effect of Jatrorrhizine on HUVECs under high glucose conditions, results showed that JAT reversed high glucose-induced downregulation of Akt/eNOS phosphorylation, alleviated ER stress and oxidative stress, and increased NO release. Int J Mol Sci. 2022 Oct 11;23(20):12064
RBL-2H3 cells 20 μg/ml and 40 μg/ml 24 hours Inhibited RBL-2H3 cell degranulation, significantly reduced β-hexosaminidase release J Allergy Clin Immunol. 2010 Dec;126(6):1208-17. e3
Human umbilical vein endothelial cells (HUVECs) 10 μg/ml 24 hours To investigate the effect of Jatrorrhizine on LPS-induced inflammatory response in HUVECs, results showed that Jatrorrhizine inhibited the HMGB1/NF-κB/NLRP3 signaling pathway. Phytomedicine. 2022 Jun;100:154083

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice High-fat diet-induced obese and diabetic mouse model Oral 50 mg/kg/day Once daily for 5 weeks To evaluate the protective effect of Jatrorrhizine on vascular function in diabetic and obese mice, results showed that JAT improved endothelium-dependent relaxations, reduced blood pressure, improved glucose tolerance and insulin sensitivity, reduced hepatic lipid accumulation, and improved plasma lipid profile. Int J Mol Sci. 2022 Oct 11;23(20):12064

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.78mL

2.96mL

1.48mL

29.55mL

5.91mL

2.96mL

References

 

Historical Records

Categories